Related Experiment Videos
Adenovirus vectors for gene delivery.
K Benihoud1, P Yeh, M Perricaudet
1Laboratoire de Vectorologie et Transfert de Gènes UMR1582 CNRS/Rhône-Poulenc Gencell/IGR Institut Gustave Roussy 94805, Villejuif, France. benihoud@igr.fr
Current Opinion in Biotechnology
|October 6, 1999
Summary
Researchers are improving adenovirus gene therapy vectors by modifying tropism and gene capacity. However, controlling the immune response to allow for repeated treatments remains a significant hurdle for adenovirus vectors.
Area of Science:
- Gene therapy
- Virology
- Immunology
Background:
- Adenovirus vectors are promising tools for gene delivery.
- Current research focuses on enhancing adenovirus vector capabilities.
- Viral gene deletions improve cloning capacity and reduce cellular immunity.
Purpose of the Study:
- To address challenges in developing effective adenovirus gene therapy vectors.
- To improve control over transgene expression and vector stability.
- To overcome limitations in readministration due to immune responses.
Main Methods:
- Modification of adenovirus tropism.
- Engineering for larger gene accommodation.
- Strategies to increase transgene expression stability and control.
Main Results:
- Partial or total viral gene deletions enhance cloning capacity.
- Reduced cellular immune response observed with gene deletions.
- Control of humoral immune response remains a challenge for readministration.
Conclusions:
- Adenovirus vector development has advanced in gene capacity and expression control.
- Reducing cellular immunity is partially achieved through gene deletions.
- Developing strategies to manage humoral immunity is critical for repeated adenovirus gene therapy administration.